DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-2,219 Cr | ₹-804 Cr | ₹-269 Cr | ₹-2,707 Cr | ₹-2,195 Cr |
What is the latest Cash Flow from Investing Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-2,219 Cr |
| Mar2025 | ₹-804 Cr |
| Mar2024 | ₹-269 Cr |
| Mar2023 | ₹-2,707 Cr |
| Mar2022 | ₹-2,195 Cr |
How is Cash Flow from Investing Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-2,219 Cr | Negative | |
| Mar2025 | ₹-804 Cr | Negative | |
| Mar2024 | ₹-269 Cr | Negative | |
| Mar2023 | ₹-2,707 Cr | Negative | |
| Mar2022 | ₹-2,195 Cr | - | |
Compare Cash Flow from Investing Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹256,340.3 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
| MANKIND PHARMA | ₹101,659.0 Cr | 11% | 0.9% | 1.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 7.5% |
1.3% |
45.7% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses